Share

EORTC presentations at ESMO World Congress on Gastrointestinal Cancer

The EORTC will present one oral abstract and one poster abstract at the 17th ESMO World Congress on Gastrointestinal Cancer which will be held 01 – 04 July 2015 in Barcelona.

Poster P-310

carmela-caballeroC. Caballero, S. Evrard, G. Poston
EORTC 1409-GITCG CLIMB: An EORTC-ESSO Prospective Colorectal Liver Metastasis Database with an Integrated Quality Assurance Program
Friday, 3 July from 10:25 to 10:55 and 16:30 to 17:00
Citation: Ann Oncol (2015) 26 (suppl 4): iv91

Oral Abstract O-018

Theo-RuersT. Ruers, C.J.A. Punt, F. van Coevorden, J.-P. Pierie, I. Borel Rinkes, J. Ledermann, G. Poston, W. Bechstein, M.-A. Lentz, M. Mauer, E. Van Cutsem, M. Lutz, B. Nordlinger
Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)
July 2015
Citation: Ann Oncol (2015) 26 (suppl 4): iv114-iv115

Follow on Twitter  #WorldGI, #EORTC

Back to news list

Related News

  • New European AI assistant to make patient experiences actionable for care and health systems

  • First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer

  • EORTC at ESMO 2026: New findings and ongoing studies

  • EORTC research presented at ESMO 2026

  • EORTC Quality of Life Group at ISOQOL 2026

  • Pink October 2026: Advancing breast cancer research, together

  • EORTC presents new results in neuro-oncology at EANO

  • In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group

  • New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults

  • New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors